Close

Endologix (ELGX) Misses Q4 EPS by 1c, FY EPS Guidance Falls Short

February 25, 2015 4:39 PM EST

Endologix (NASDAQ: ELGX) reported Q4 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $38.8 million versus the consensus estimate of $38.1 million.

Endologix sees FY2015 EPS of ($0.51)-($0.56), versus the consensus of ($0.42). Endologix sees FY2015 revenue of $159-165 million, versus the consensus of $163.4 million.

For earnings history and earnings-related data on Endologix (ELGX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings